Clincosm LogoSign in Get a demo

Non-alcoholic Steatohepatitis

Showing 26 - 50 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis Trial in Ann Arbor (Usual Care then FitBit, FitBit then Usual

Completed
Has Results
  • Non-Alcoholic Fatty Liver Disease
  • Non-alcoholic Steatohepatitis
  • Usual Care then FitBit
  • FitBit then Usual Care
  • Ann Arbor, Michigan
    The University of Michigan
Apr 5, 2022

Non-alcoholic Steatohepatitis Trial (Dapagliflozin 10Mg Tab, Pioglitazone 30 mg)

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • Dapagliflozin 10Mg Tab
  • Pioglitazone 30 mg
  • (no location specified)
Apr 23, 2022

Non-alcoholic Steatohepatitis Trial in Worldwide (NNC0194 0499 50 mg/mL, Placebo (NNC0194-0499), Semaglutide 3 mg/mL)

Recruiting
  • Non-alcoholic Steatohepatitis
  • NNC0194 0499 50 mg/mL
  • +5 more
  • Huntsville, Alabama
  • +135 more
Apr 7, 2022

Non-alcoholic Steatohepatitis Trial in Tokyo (NNC0194-0499, Placebo (NNC0194-0499 ))

Completed
  • Non-alcoholic Steatohepatitis
  • Tokyo, Japan
    Novo Nordisk Investigational Site
Apr 4, 2022

Non-Alcoholic Fatty Liver Disease, Metabolic Encephalopathy, Obesity, Morbid Trial in Esbjerg (Bariatric surgery)

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Bariatric surgery
  • Esbjerg, Denmark
    Hospital of Southwest Jutland
Mar 15, 2022

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver, Non-alcoholic Steatohepatitis Trial in Maastricht, Cambridge,

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +2 more
    • Maastricht, Netherlands
    • +2 more
    Feb 17, 2022

    Non-Alcoholic Steatohepatitis Trial in Worldwide (Yaq-001, Placebo)

    Withdrawn
    • Non-Alcoholic Steatohepatitis
    • Yaq-001
    • Placebo
    • Clichy, France
    • +8 more
    Feb 14, 2022

    Non-alcoholic Steatohepatitis Trial in Marietta (Noom Healthy Weight)

    Completed
    • Non-alcoholic Steatohepatitis
    • Noom Healthy Weight
    • Marietta, Pennsylvania
      Penn State Hershey Medical Center
    Mar 1, 2022

    Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, NAFLD Trial in Singapore (MLCT Oil, LCT Oil (Corn Oil))

    Enrolling by invitation
    • Non-Alcoholic Fatty Liver Disease
    • +2 more
    • MLCT Oil
    • LCT Oil (Corn Oil)
    • Singapore, Singapore
      National University Hospital
    Feb 8, 2022

    Cirrhosis, Portal Hypertension, Non-alcoholic Steatohepatitis Trial in Germany, Spain, United States (Emricasan, Placebo)

    Completed
    Has Results
    • Cirrhosis
    • +2 more
    • Pasadena, California
    • +36 more
    Jan 13, 2022

    Rheumatoid Arthritis, Non-Alcoholic Steatohepatitis Trial in Adelaide (LB-P6, LB-P8, Placebo)

    Recruiting
    • Rheumatoid Arthritis
    • Non-Alcoholic Steatohepatitis
    • Adelaide, Australia
      Cmax Clinical Research
    Dec 22, 2021

    Integrated Diagnostics for Early Diagnosis of Liver Disease

    Recruiting
    • Non-Alcoholic Fatty Liver Disease
    • +3 more
    • Blood tests for Single Nucleotide Polymorphisms
    • +2 more
    • Manchester, Greater Manchester, United Kingdom
      Manchester University NHS Foundation Trust
    Dec 13, 2021

    Non-alcoholic Fatty Liver Disease

    Recruiting
    • Non-Alcoholic Fatty Liver Disease Without Non-Alcoholic Steatohepatitis (Disorder)
    • Non-alcoholic Steatohepatitis
    • Bariatric Surgery
    • London, Greater London, United Kingdom
      Homerton University Hospital Foundation Trust
    Nov 25, 2021

    Non-alcoholic Steatohepatitis Trial in Grafton (ARO-HSD Injection, sterile normal saline (0.9% NaCl))

    Completed
    • Non-alcoholic Steatohepatitis
    • ARO-HSD Injection
    • sterile normal saline (0.9% NaCl)
    • Grafton, Auckland, New Zealand
      Auckland Clinical Studies
    Dec 2, 2021

    Metabolic Disorders, Non-alcoholic Steatohepatitis Trial in Glendale (AZD2693, Placebo)

    Completed
    • Metabolic Disorders
    • Non-alcoholic Steatohepatitis
    • Glendale, California
      Research Site
    Nov 24, 2021

    Hepatobiliary Disorders, Non-alcoholic Steatohepatitis Trial in Worldwide (Semaglutide, Placebo)

    Completed
    Has Results
    • Hepatobiliary Disorders
    • Non-alcoholic Steatohepatitis
    • Birmingham, Alabama
    • +157 more
    Nov 15, 2021

    Non-alcoholic Steatohepatitis Trial in Worldwide (EYP001a, Placebo)

    Completed
    • Non-alcoholic Steatohepatitis
    • North Little Rock, Arkansas
    • +41 more
    Sep 13, 2021

    Non-Alcoholic Steatohepatitis Trial in Worldwide (EDP-305 Dose 1, EDP-305 Dose 2, Placebo)

    Completed
    Has Results
    • Non-Alcoholic Steatohepatitis
    • EDP-305 Dose 1
    • +2 more
    • Chandler, Arizona
    • +81 more
    Aug 19, 2021

    Non-alcoholic Steatohepatitis Trial in Sydney (HEC88473 injection, Placebo)

    Recruiting
    • Non-alcoholic Steatohepatitis
    • HEC88473 injection
    • Placebo
    • Sydney, Australia
      Scientia Clinical Research
    Aug 25, 2021

    Non-alcoholic Steatohepatitis Trial in Mexico City (metadoxine, )

    Suspended
    • Non-alcoholic Steatohepatitis
    • Mexico City, DF, Mexico
      Hospital General de México
    Aug 26, 2021

    Fatty Liver, Non-Alcoholic Steatohepatitis, Liver Diseases Trial in Worldwide (Aramchol)

    Completed
    Has Results
    • Fatty Liver
    • +3 more
    • Chula Vista, California
    • +77 more
    Jun 24, 2021

    Fibrosis, Inflammation, Idiopathic Pulmonary Fibrosis Trial in Merthyr Tydfil (RXC007, RXC007 Matching Placebo)

    Recruiting
    • Fibrosis
    • +5 more
    • Merthyr Tydfil, Mid Glamorgan, United Kingdom
      Simbec-Orion Clinical Pharmacology
    Jun 11, 2021

    Non-Alcoholic Steatohepatitis Trial in Worldwide (EDP-305 1.5 mg, EDP-305 2 mg, Placebo)

    Recruiting
    • Non-Alcoholic Steatohepatitis
    • EDP-305 1.5 mg
    • +2 more
    • Chandler, Arizona
    • +85 more
    Jun 10, 2021

    Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis Trial in Melbourne (HEC96719)

    Completed
    • Non-alcoholic Fatty Liver Disease
    • Non-alcoholic Steatohepatitis
    • Melbourne, Melbourne VIC 3004, Australia
      Nucleus Network Pty Ltd
    May 6, 2021

    Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, NAFLD Trial in Maastricht (Plant stanols (3g/day), Placebo)

    Not yet recruiting
    • Non-Alcoholic Fatty Liver Disease
    • +7 more
    • Plant stanols (3g/day)
    • Placebo
    • Maastricht, Netherlands
      Maastricht University Medical Center
    Mar 2, 2021